A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Wanwisa Dejnirattisai(Hammersmith Hospital), Gavin Screaton(University of Oxford), Thaneeya Duangchinda(National Science and Technology Development Agency), Wiyada Wongwiwat(Hammersmith Hospital), Alexander Rouvinski(Atkins (United States)), Prida Malasit(Siriraj Hospital), Xinghong Dai(Case Western Reserve University), F.A. Rey(Institut Pasteur), Sunpetchuda Supasa(Siriraj Hospital), Cameron P. Simmons(The University of Melbourne), Juthathip Mongkolsapaya(Centre for Human Genetics), Jonathan M. Grimes(Centre for Human Genetics), Nguyen Than Ha Quyen(Oxford University Clinical Research Unit), Amonrat Jumnainsong(Khon Kaen University), Jeremy Farrar(World Health Organization), Wei‐Kung Wang(University of Hawaiʻi at Mānoa), Xiaokang Zhang(Center for Excellence in Brain Science and Intelligence Technology), Chih-Yun Lai(University of Hawaiʻi at Mānoa), Wen-Yang Tsai(University of Hawaiʻi at Mānoa), Carolyn Edwards(Hammersmith Hospital), Zehua Zhou(California NanoSystems Institute)
Cited by 497
Related Papers
The global distribution and burden of dengue
|Nature|2013|10.1k
Dengue: a continuing global threat
|Nature Reviews Microbiology|2010|2.1k
Into the Eye of the Cytokine Storm
|Microbiology and Molecular Biology Reviews|2012|2k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Dengue
|New England Journal of Medicine|2012|1.7k